LOVENOX HP SOLUTION

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

ENOXAPARIN SODIUM

Available from:

SANOFI-AVENTIS CANADA INC

ATC code:

B01AB05

INN (International Name):

ENOXAPARIN

Dosage:

120MG

Pharmaceutical form:

SOLUTION

Composition:

ENOXAPARIN SODIUM 120MG

Administration route:

SUBCUTANEOUS

Units in package:

10

Prescription type:

Prescription

Therapeutic area:

HEPARINS

Product summary:

Active ingredient group (AIG) number: 0131860002; AHFS:

Authorization status:

APPROVED

Authorization date:

2012-02-03

Summary of Product characteristics

_Product Monograph – LOVENOX (enoxaparin) _
_Page 1 of 111_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
Pr
LOVENOX
®
Enoxaparin sodium solution for injection
30 mg in 0.3 mL solution (100 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
40 mg in 0.4 mL solution (100 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
60 mg in 0.6 mL solution (100 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
80 mg in 0.8 mL solution (100 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
100 mg in 1 mL solution (100 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
300 mg in 3 mL solution (100 mg/mL), multidose vials for subcutaneous
or intravenous
injection
Pr
LOVENOX
®
HP
Enoxaparin sodium (High Potency) solution for injection
120 mg in 0.8 mL solution (150 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
150 mg in 1 mL solution (150 mg/mL), pre-filled syringes for
subcutaneous or intravenous
injection
Manufacturer’s standard
Anticoagulant/Antithrombotic Agent
ATC Code: B01AB05
_ _
_Product Monograph – LOVENOX (enoxaparin) _
_Page 2 of 111_
sanofi-aventis Canada Inc.
2905 Place Louis-R.-Renaud
Laval, Quebec H7V 0A3
Date of Initial Approval:
February 9, 1993
Date of Revision
September 7, 2021
Submission Control Number: 252514
_ _
_Product Monograph – LOVENOX (enoxaparin) _
_Page 3 of 111_
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
TABLE OF CONTENTS
................................................................................................................3
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................................5
1
INDICATIONS
................................................................................................................5
1.1
Pediatrics
...........................................................................................................